Recent Updates
Recently added Catalysts
FULC Positive Sentiment

Fulcrum Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Thursday, February 6, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Fulcrum Therapeutics, a clinical-stage biopharmaceutical company, announced its participation in the virtual Oppenheimer 35th Annual Healthcare Life Sciences Conference. Management will engage in a fireside chat scheduled for February 12, 2025, at 1:20 pm ET. The event emphasizes the company's commitment to addressing rare genetic diseases. A playback of the discussion will be available on their website for at least 30 days post-event.
Price reaction · baseline $3.91 (2025-02-05 close) · hit after-hours · 1 other FULC headline(s) in the window, move may be shared
day 0 close · peak
-2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Fulcrum Therapeutics is participating in a significant healthcare conference.
  • The company focuses on developing treatments for rare genetic diseases, highlighting its innovative approach.
  • The presentation provides an opportunity to engage with the broader healthcare community.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+32%
120-day peak, hindsight
Typical move
15.6%
average across 6 past catalysts
Cash runway
~59 mo
Minimal dilution risk
Lead asset
Pociredir
Phase 2 · Sickle Cell Disease

Full Press Release Details

CAMBRIDGE, Mass., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that management will participate in a fireside chat at the virtual Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12, 2025 at 1:20 pm ET.
The webcast of the fireside chat will be accessible HERE and by visiting the "Events and Presentations" section of Fulcrum Therapeutics’ website at https://ir.fulcrumtx.com/events-and-presentations. A replay of the webcast will be available on Fulcrum Therapeutics’ website for at least 30 days following the presentation.
About Fulcrum Therapeutics

Frequently Asked Questions

When is Fulcrum Therapeutics' fireside chat scheduled?

The fireside chat is set for February 12, 2025, at 1:20 pm ET.

Where can I watch the Fulcrum Therapeutics webcast?

The webcast can be accessed through Fulcrum's website under the Events section.

How long will the webcast replay be available?

A replay of the webcast will be available for at least 30 days.

What is the focus of Fulcrum Therapeutics?

The company focuses on developing small molecules for rare genetic diseases.

ShareAdd on Google
Tags: FULC Viatris Investor Conferences Healthcare Fulcrum Therapeutics Oppenheimer Conference healthcare biopharmaceutical genetic diseases
Last updated: Feb 6, 2025

Biotech snapshot

Cash runway
$319M liquidity · $5M/mo burn
~59 mo
Minimal dilution risk
Lead asset
PociredirPhase 2
Sickle Cell Disease →

Catalyst track record

+32%
best trade around FULC's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for FULC.

See every catalyst's timing & PoA →